Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China · Delayed Price · Currency is CNY 54.42
+2.26 (4.33%)
At close: Aug 20, 2026
SHE:301075 Market Cap
SHE:301075 has a market cap or net worth of 4.12 billion as of August 20, 2026. Its market cap has increased by 36.65% in one year.
Market Cap
4.12B
Enterprise Value
4.52B
Revenue
137.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.42
ChartMarket Cap Chart
Since September 29, 2021, SHE:301075's market cap has increased from 3.59B to 4.12B, an increase of 14.63%. That is a compound annual growth rate of 2.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 4.12B | -12.59% |
| Dec 31, 2025 | 4.71B | 232.05% |
| Dec 31, 2024 | 1.42B | -33.50% |
| Dec 29, 2023 | 2.13B | -17.53% |
| Dec 30, 2022 | 2.59B | -16.89% |
| Dec 31, 2021 | 3.11B | -13.36% |
| Sep 29, 2021 | 3.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harbin Medisan Pharmaceutical | 4.72B |
| Zhejiang Yatai Pharmaceutical | 4.64B |
| Hunan Fangsheng Pharmaceutical | 4.61B |
| Tianjin Lisheng Pharmaceutical | 4.56B |
| Sinotherapeutics | 4.52B |
| Lionco Pharmaceutical Group | 4.47B |
| Shenzhen Neptunus Bioengineering | 4.39B |
| Jianmin Pharmaceutical Group | 4.38B |